Seminomas are characterized by expression of several stem cell markers, supporting their origin from germ cells. The current study focuses on novel germ cell markers in normal testes compared to those in fetal testes and different progression stages of seminomas. Microarray data were followed by RT -PCRs and immunohistochemistry on pure seminomas (pT1 to pT3) compared to adult and fetal testis. An upregulation of known germ cell markers, KIT, OCT4 and NANOG, was confirmed in seminoma specimens. We also identified novel germ cell markers such as BOB1 (POU2AF1, OBF1) and prominin 1 (PROM1, CD133), which were significantly upregulated in seminoma specimens, compared to normal testes. Furthermore, two Sertoli cell markers, SCGF (SCF) and the newly identified neuronal stem cell factor, MCFD2 (SDNSF), were expressed in seminoma cells. While BOB1 was expressed in fetal testis of second and third trimester of gestation, MCFD2 and PROM1 were only present in gonocytes up to the second trimester. All marker genes investigated were not further regulated in progressing tumour stages between pT1 and pT3. In conclusion, the germ cell markers described here provide evidence for the origin of seminoma cells, which could be from the developmental stage of early gonocytes or from spermatogonia re-expressing markers of the developing germ cells.
Introduction
The incidence of testicular germ cell tumours has doubled in the past 40 years (Horwich et al., 2006) . This increase suggests that critical changes in environmental factors are contributing to the development of these tumours (Horwich et al., 2006) . Extensive karyotypic and genomic studies on seminoma lead to two discrete hypotheses for the onset of tumour formation as reviewed recently . One model suggests aberrant recombination in a spermatocyte (4n) resulting in 12p-gain and formation of seminoma (Chaganti and Houldsworth, 1998) . The second, currently widely accepted model for the origin of testicular germ cell tumours proposes a very early block in maturation during fetal development (Skakkebaek et al., 1987; Rajpert-De Meyts, et al. 1998; Honecker et al., 2004a,b; Horwich et al., 2006) . It has been thought that primary germ cells may develop into an intratubular germ cell neoplasia (ITGCN, carcinoma in situ) and remain at this stage until adulthood. ITGCN cells show similarities to embryonic germ cells, such as their positiveness for placental-like alkaline phosphatase (Jacobsen and Norgaard-Pedersen, 1984) , the stem cell factor receptor KIT, OCT4 (Honecker et al., 2004a,b) and their glycogen content (Dieckmann and Skakkebaek, 1999) . However, the underlying molecular mechanisms as well as the time point of germ cell transformation into ITGCN or fully developed seminoma are poorly understood.
Recently, several microarray studies have been performed to identify new diagnostic markers (Okada et al., 2003; Yamada et al., 2004) and to investigate the origin, (Sperger et al., 2003; Almstrup et al., 2004; Korkola et al., 2006) as well as genes characterizing progression, of seminoma . These investigations have led to new insights into the pathogenesis of this tumour entity by describing their stem cell-like character (Sperger et al., 2003; Almstrup et al., 2004) . Applying supervised analyses, we have described additional germ cell marker genes for seminoma such as MCFD2, BOB1 and PROM1, by focusing on their expression pattern.
These germ cell markers may be important for both tumorigenesis and the maintenance of the tumour. In this study, we specifically examined those transcripts known to be important for early differentiation processes and which play a role during migration, self-renewal, pluripotency or survival of cells. We aimed to identify the initial time point of transformation to seminoma by investigating the temporal expression patterns of these factors during testes development as well as in different tumour stages.
Materials and methods

Tissue samples
As already described , we performed microarray analyses of 43 testicular tissue samples out of 72 specimens, including nine normal testes and 63 tumour specimens. The distribution of the different stages of pure seminoma was: stage pT1, n ¼ 40; pT2, n ¼ 19; and pT3, n ¼ 4. The clinicopathological data of the patients have been described in the reference Gashaw et al. (2005) .
Here, an additional 12 fetal testes were examined including eight testes from second trimester (14th, 16th, 21st, 22nd, 23rd and 26th weeks of pregnancy) as well as four testes from third trimester (30th, 32nd and 37th weeks of pregnancy). All fetal tissues were obtained for diagnostic or documentary reasons because of fetal or stillborn deaths (amnion infection or premature rupture, congenital heart failure). One prepubertal testicular tissue biopsy was obtained from a five year-old boy because of 5a-reductase deficiency.
All specimens were collected in accordance with the guidelines approved by the local ethics committees.
mRNA expression analyses
RNA preparation, cDNA synthesis and microarray analyses have been described previously . Briefly, all biopsies of the tumour specimens were carefully investigated before further processing by staining one frozen section with toluidin blue and only those containing pure seminoma tissues, as classified by a pathologist, were used for RNA extraction. The RNA was extracted as described and only samples of high quality RNA were further processed and finally hybridized to a HG-U95Av2 chip . Global scaling was applied to allow comparison of gene signals across multiple microarrays. Annotations of the probe sets were taken from material provided on the Affymetrix homepage (Liu et al., 2003) .
Semi-quantitative competitive RT -PCRs were performed in triplicates for chosen markers, such as KIT, SCGF, OCT4, NANOG, BOB1, MCFD2 and PROM1, on samples from the above cohort of patients including a total of 23 specimens analysed previously by microarrays (2 Â NT, 11 Â pT1, 6 Â pT2 and 4 Â pT3) and 11 additional tissues (4 Â NT, 6 Â pT1 and 1 Â pT2) for which the RNA was either of poor quality or the quantity was not sufficient for microarray analysis. Primer sequences used in the PCRs are available in Table 1 . Since most of the frequently used housekeeping genes were differentially expressed in seminoma , the constantly expressed UBB (Ubiquitin B) mRNA was co-amplified as an internal standard in each experiment. In the densitometric analyses (Scion Image software, Scion Corporation, Frederick, MD, USA), the signal intensity of the target gene was related to the signal intensity of the UBB amplicon.
Immunohistochemical analyses
Formalin-fixed, paraffin-embedded sections from seven patients with seminoma (pT1) were randomly selected from the group described above. In addition, 12 prenatal, one prepubertal and three adult testicular biopsies were used for immunohistochemical analyses.
Immunostaining procedures were performed for SCGF, MCFD2, BOB1 and PROM1 using an adequate Vectastain ABC Elite Kit (Vector Laboratories, Burlingame, CA, USA) according to the manufacturer's protocol. All sections were incubated over night at 48C with the primary antibody. Goat anti-human MCFD2 antibody (R&D Systems, Wiesbaden, Germany) and rabbit anti-human BOB1 (sc-955, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) were specific for the respective protein (Marafioti et al., 2003; Nyfeler et al., 2006) and were used at 10 mg/ml. For SCGF and PROM1 localization, the sections were subjected to antigen retrieval in 0.01 M sodium citrate (pH 6.0) followed by incubation with polyclonal goat anti-SCGF antibody (1:50; sc-1302, Santa Cruz Biotechnology Inc.) or monoclonal murine anti-PROM1 antibody (25 mg/ml, ABGENT, San Diego, CA, USA), respectively. Control sections were stained according to the same protocol with buffer instead of the primary antibody. Colour visualization was performed using DAB (DakoCytomation, Hamburg, Germany) as chromogen substrate. Sections were counterstained with haematoxylin, and examined with an Axiophot microscope (Carl Zeiss, Jena, Germany) equipped with a Nikon DS-U1 camera and LUCIA Image Analysis software (Version 5.0, Nikon, Düsseldorf, Germany).
Statistical analysis
Statistical analyses performed in course of microarray studies were precisely described previously . Exploratory data analysis, the nonparametric Kruskal-Wallis test as well as the Mann-Whitney test for the nonparametric independent two-group comparisons and Pearson's correlation were performed with the program SPSS 14 for Windows (SPSS Inc, Chicago, IL, USA). Differences with P 0.05 were regarded as statistically significant.
Results
Germ cell markers are regulated in seminoma
The microarray data, which have been deposited in the National Centre for Biotechnology Information Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo/; accession no: GSE8607), revealed 1490 differentially regulated genes in 40 seminoma of different stages compared to three normal testicular specimens . According to the aim of the study, annotations of all probe sets were scanned for the term: 'stem cells'. To set a cutoff for regulated stem cell genes, only transcripts expressed in at least 30 out of 43 tissue samples (70%) were further investigated. At least 14 transcripts fulfilled the criteria described above ( Table 2 ) and 10 of those transcripts were significantly regulated in seminoma. Of these, eight genes were significantly upregulated: OCT4, ALPL, BOB1, KIT, CD9, THY1, PUM2 and PROM1, with more than four-fold increase in expression when compared to normal testis (for further characterization of the genes, see Table 2 ). Transcripts of MCFD2 and PIWIL1 were downregulated (Table 2 ). The probes of the other well-known stem cells markers such as NANOG, STELLAR and GDF3 were absent from the HG-U95Av2 chip. Five of the regulated transcripts (OCT4, ALPL, KIT, PROM1 and PIWIL1) were already described for their presence in seminoma. In addition, two novel interesting genes, BOB1 and MCFD2, have been identified in this study. We further focused on those genes, which were significantly differentially regulated between normal testis and seminoma and verified the microarray data by applying semi-quantitative RT-PCR and immunohistochemistry. We confirmed the expression of KIT, OCT4 and NANOG mRNA in seminoma specimens (Fig. 1) as already described by Honecker et al. (2004a,b) and Ezeh et al. (2005) . However, our data showed that these stem cell markers (KIT, OCT4, NANOG), although significantly upregulated in all tumour tissues compared to normal tissue, revealed no obvious regulation associated with the progressing tumour stages from pT1 to pT3 (Table 2 , Fig. 1) .
In contrast to other investigators (Strohmeyer et al., 1995; Bokemeyer et al., 1996) , we identified the KIT ligand SCGF in seminoma specimens at the mRNA level (Table 2, Fig. 1B) . The transcripts were expressed in all tumours without a significant regulation compared to normal testes (Fig. 1B) . SCGF immunoreactivity was localized in the cytoplasm of intratubular tumour cells as well as in nearly all seminoma cells ( Fig. 2A and B) .
MCFD2 is present in Sertoli cells and in seminoma cells
MCFD2 was significantly downregulated in seminoma specimens in the microarray analysis (Table 2 ). However interestingly, the corresponding RT-PCR analysis from 16 samples (10 analysed already by microarrays and six additional; 2 Â NT, 3 Â pT1, 1 Â pT2) showed a constant transcript expression in all tumour specimens compared to normal testes (Fig. 1F) . When investigating testis with regular spermatogenesis, we observed the presence of immunoreactive MCFD2 protein in the cytoplasm of Sertoli cells (Fig. 2C ) but all spermatogonia were negative for MCFD2 (Fig. 2C) . Moreover, we localized the MCFD2 protein to intratubular tumour cells and remaining Sertoli cells (Fig. 2D ). As presented in Fig. 2D , not all intratubular tumour cells were positive for MCFD2 but nearly all seminoma cells were. Thus, the immunostaining procedures confirmed the results of the semi-quantitative RT-PCR, validating constantly expressed MCFD2 in seminoma.
By investigating fetal testis, the MCFD2 protein was identified in gonocytes and Sertoli cells from the second trimester of gestation (Fig. 2E) , whereas in testes of the third trimester, the MCFD2 protein staining had disappeared as presented in Fig. 2F . All investigations confirmed that MCFD2 is expressed by gonocytes and Sertoli cells in second trimester, but is restricted later to Sertoli cells of adult testis. Thus, MCFD2 is maintained in some cells of ITGCN and in all seminoma cells.
BOB1 is expressed in testicular germ cells and highly upregulated in seminoma
The microarray data revealed an average 22-fold increased expression of BOB1 in all seminoma specimens compared to normal testes (Table 2 ). This could be confirmed by RT-PCR. Among the seminoma investigated, the transcripts of BOB1 mRNA revealed high inter-individual differences in expression levels ( Fig. 1E ) with a mean 30-fold upregulation in tumours when compared to controls (range: 2.3-85.3-fold). Similar to the expression pattern of the above described stem cell markers KIT, OCT4 and NANOG, expression levels of BOB1 mRNA remained steadily high in the different tumour stages investigated. Figure 3 illustrates the localization of BOB1 protein in testicular tissues. Testis with regular spermatogenesis showed strong positive a The P-call is an indicator of the presence of a positive hybridization signal for a specific gene on an array and describes the number of positive samples (as a percentage). Factor 'I' denotes the intensity of the upregulation resulting from an increase in signal intensity on the array. *The P-value was estimated applying the Mann-Whitney test.
Novel germ cell markers in seminoma nuclear staining for BOB1 protein within the germ cell epithelial layer from spermatogonia up to spermatids (Fig. 3A) . The nuclei of most spermatogonia and of all Sertoli cells were immunoreactive to BOB1 (Fig. 3A) . Cells of ITGCN and of the tumour revealed very strong, predominantly nuclear staining for BOB1 as illustrated in Fig. 3B and C, respectively. Infiltrating leukocytes were negative for BOB1 (Fig. 3C ). All controls revealed no unspecific binding as presented in Fig. 3D . The gonocytes of second and third trimester of gestation were positive for BOB1 as illustrated in Fig. 3E and F, respectively. Similar to the situation in adult testis, BOB1 negative gonocytes and some positive Sertoli cells were present in the tubules of fetal testes.
Upregulation of PROM1 is an early event in the pathogenesis of seminoma
Microarray analyses showed a significant 4.3-fold upregulation of PROM1 transcripts in tumour tissues (Table 2) . Semi-quantitative RT-PCR analyses confirmed the upregulation with a mean 64-fold factor of increase (Fig. 1G) indicating a very strong upregulation of PROM1 mRNA expression in seminoma. Normal testicular tissue showed no signal at 26 cycles and only a weak signal at 35 cycles, when the cDNA from tumour specimens reached already the saturation of amplification (Fig. 1G ). PROM1 mRNA expression was maintained at high levels in all tumour stages investigated (Fig. 1G) . Though PROM1 was strongly expressed in the apical region of the epididymal epithelium, which was chosen as a positive control (Fig. 4A) , only sporadic specific immunostaining could be detected in spermatogonia of tissues with regular spermatogenesis (Fig. 4B) . However, the protein was localized at the cell membranes of preinvasive tumour cells (Fig. 4C) . Interestingly, the strong prominin expression in seminoma cells was not only restricted to the membranes but was also present in the cytoplasm of tumour cells (Fig. 4D ). In addition, prominin was also detected in the stromal compartment including lymphocytes (Fig. 4D) , a fact which could contribute to high mRNA levels of PROM1 seen in tumour tissues. Thus, the immunohistochemical analysis (Fig. 4) confirmed the transcript expression pattern for PROM1 (Fig. 1) , regarding its weak expression in normal testis and a high upregulation in seminoma. Moreover, the upregulation of PROM1 seems to be a very early event in the pathogenesis of germ cell tumours because of its strong staining in the ITGCN (Fig. 4C ). PROM1 positive germ cells were found in the seminiferous tubules of second trimester fetal testes as illustrated in Fig. 4E . Similar to the expression pattern seen in seminoma cells, germ cells from second trimester showed membranous and cytoplasmatic staining for the PROM1 protein. The latest expression of PROM1 observed was in a testis from the 26th week of gestation. The protein was absent from testicular tissues in third trimester as shown in Fig. 4F .
Discussion
Numerous data exist for expression of different stem cell markers such as KIT, OCT4, NANOG and PIWIL1 in seminoma (Qiao et al., 2002; Honecker et al., 2004a,b; Ezeh et al., 2005) . Re-investigating our microarray data , we confirmed the expression pattern of five known markers in the tumour. Remarkably, we could identify three novel germ cell factors, BOB1, MCFD2 and PROM1, elevated in seminoma compared to the adult testis. For the first time, we demonstrated that all germ cell markers investigated revealed no further regulation in low (pT1) versus advanced seminoma stages (pT3). These constantly high levels further confirm that seminoma maintain their germ cell characters during tumour progression.
In contrast to the literature, which describes that testicular seminomas express KIT (Honecker et al., 2004a,b) but do not express its ligand SCGF (Strohmeyer et al., 1995; Bokemeyer et al., 1996) , we showed a constitutive expression of SCGF in seminoma cells on mRNA and protein level. The other stem cell marker, MCFD2 was not known to be expressed in seminoma as well as in testicular tissues before. The MCFD2 gene (multiple coagulation factor deficiency 2 protein, SDNSF) encodes the neural stem cell derived protein and is discussed as a factor maintaining stem cell potential in adult central nervous system (Toda et al., 2003) . In contrast to previously described stem cell markers, such as KIT and hiwi which have been localized to germ cells and later on to spermatogonia in adult testis (Rajpert-De Meyts, 2006), we localized MCFD2 protein to testicular Sertoli cells.
Interestingly, MCFD2 was significantly downregulated in seminoma specimens in microarray analyses but not in RT-PCR and immunohistochemistry. We traced back this discrepancy to the probesets used for the hybridization on the array, which anneal to the 3 0 untranslated region, whereas the PCR primers were placed into two exons and are more appropriate for interpretation of data. In addition, the detection of high protein levels in tumour tissues confirmed the RT-PCR data.
Among the germ cell markers upregulated in seminoma, we found PROM1 (CD133). Prominin 1 was originally found on neuroepithelial stem cells in mice (Shmelkov et al., 2005) and is also expressed in embryonal carcinoma cells (Chadalavada et al., 2007) . Prominin has been reported to be responsible for initiation of new brain tumours (Singh et al., 2004) . Recently, PROM1 was identified via microarray analyses in seminoma (Looijenga et al., 2006) , but without further characterization. We present herewith for the first time the expression pattern of PROM1 mRNA and protein in human testicular tissues. The levels of PROM1 mRNA were very weak in normal testicular tissue and only sporadic spermatogonial immunostaining could be observed. The murine homologue of PROM1 has been detected previously on the tail of developing spermatozoa (Fargeas et al., 2004) , a finding we failed to confirm for human testicular tissues, although the same antibody showed a strong positive signal on epididymal tissues used as a control and confirmed the results found in the mouse (Fargeas et al., 2004) . Intratubular tumour cells as well as seminoma specimens revealed strong signals for PROM1. Like MCFD2, PROM1 was only detected in fetal testis of the second, and not third, trimester. BOB1 (POU2AF1, OBF1) is more a germ cell factor than a stem cell marker. BOB1 represents a transcription factor predominantly expressed in human tissues of lymphoid origin and is required for germinal centre formation (Teitell, 2003) . In our study, BOB1 protein present in germ cells of adult testis was highly upregulated in seminoma and was expressed in fetal testis up to the third trimester. Thus, BOB1 is a novel testicular germ cell marker probably involved in the pathogenesis of seminoma.
All stem cells markers previously described are expressed in gonocytes and many of them in germ cells of adult testis (Rajpert-De Meyts, 2006) . Germ cells that are predominantly found before 25th week of development co-express OCT3/4, KIT and AP-2g (Pauls et al., 2006) . These authors stated that after 25th week, most germ cells have lost their pluripotent potential and acquired a spermatogonial phenotype (Pauls et al., 2006) . Since MCFD2 and PROM1 are expressed in gonocytes of fetal testis only until the second trimester, the origin of seminoma cells could derive latest from a second trimester gonocyte or from a spermatogonia or spermatocyte (Chaganti and Houldsworth, 1998) re-expressing markers of an early gonocyte. 
